arXiv:2606.06516q-bio.QMcs.LG2026-06

用概率模型提前预测移植患者肝静脉闭塞病严重程度,辅助个性化治疗决策。

Probabilistic learning to perform pre-onset individualised prediction of disease severity: application to Veno Occlusive Disease

论文配图:Probabilistic learning to perform pre-onset individualised prediction of disease severity: application to Veno Occlusive Disease
图 1 · 摘自论文原文
  • 构建随机函数模型,学习移植前特征与疾病严重度评分的映射关系。
  • 通过逆向概率生成数据扩充训练集,提升预测可靠性。
  • 可为血液肿瘤医生提供个体化风险评估,指导是否使用Defibrotide治疗。

本文提出一种新的概率监督学习方法,实现对前瞻性患者疾病发展严重程度的可靠、自动化和早期个体化预测。以骨髓移植前预测肝静脉闭塞病(Veno Occlusive Disease, VOD)严重度评分为例,该评分表征患者在移植后疾病的发展程度。通过将移植前变量与严重度评分之间的关系建模为特定随机过程的样本函数,利用回顾性患者群体实时演化数据生成训练集,并通过概率逆向学习生成前瞻性患者的评分数据以扩充训练集。由此训练出的函数可在移植前阶段自动预测每位患者数字孪生体(DT)对应的VOD严重度评分,该结果反馈给临床医生,用于决定是否使用Defibrotide进行治疗。已开发人工智能系统,支持医生输入患者移植前状态信息完成自动化预测。

原文摘要 · Abstract (English)

We advance a new probabilistic supervised learning approach that permits reliable, automated, and early individualised prediction of the severity with which a disease will develop in a prospective patient. The prediction capacity is illustrated via the pre-transplant prediction of the score of severity of Veno Occlusive Disease (or VOD) in the digital twin (DT) of the considered prospective patient, where this score parametrises the severity with which VOD will develop in this patient, after they undergo their Bone Marrow Transplant. The learning of the relationship between the pre-transplant variables, and a severity score variable is undertaken by modelling this relationship as a (random) function that is treated as a sample function of an adequately-chosen stochastic process. The parameters of this underlying process are learnt using a training dataset that is generated using the real-time evolution of retrospective patients in a cohort, with this training dataset subsequently augmented in size by a probabilistic inverse learning of the score of prospective patients. The augmented training set, then permits the learning of the function that capacitates - at the pre-transplant stage - automated prediction of the score of the severity of VOD that characterises the DT of a physical patient in their unique pre-transplant state. This score is subsequently fed back to the real prospective patient as the severity with which VOD will develop in them, after this patient undergoes their transplant. Such a score then permits the treating Haematologist-Oncologists to decide on the treatment regimen, which in this illustration reduces to deciding on treating the patient with Defibrotide. An AI facility is developed to undertake such automated prediction, with the physician inputting the data on the pre-transplant state that characterises the DT of the prospective patient under consideration.

疾病预测概率模型AI医疗

Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。